Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths
worldwide and is increasing in incidence. Local ablative therapy plays a leading role in HCC …

The morbidity associated with pancreatectomies limits surgical options for high-risk patients
with pancreatic neoplasms that warrant resection. Endoscopic ultrasound-guided …

Cancer is the leading cause of death in older adults aged 60 to 79 years. Older patients with
good performance status are able to tolerate commonly used treatment modalities as well as …

Background Defects of autophagy and endoplasmic reticulum (ER) stress are related to
many diseases and tumors. However, only a few studies have examined hepatocellular …

Objective: We reviewed nationwide follow-up data to determine outcomes of different
treatments for early-stage hepatocellular carcinoma (HCC) in elderly patients. Summary …

Background and aims The optimal treatment strategy for recurrent hepatocellular carcinoma
(HCC) remains unclear. Therefore, we aimed to compare the outcomes of repeat hepatic …

Self-expandable metal stents (SEMS) are the current standard of care for the palliative
management of malignant biliary strictures. Recently, endoscopic ablative techniques with …

Hepatocellular carcinoma is the most common malignancy in liver, is also a global problem
and is the fourth most commonly diagnosed cancers among men and the fourth leading …

Background: Because of the poor health conditions of elderly patients (age> 65) with very-
early-stage and early-stage hepatocellular carcinoma (HCC), primary treatment via hepatic …

Background Hepatocellular carcinoma (HCC) has variable etiological risk factors.
Radiofrequency ablation (RFA) and surgical resection (SR) are frequently used as curative …